Literature DB >> 33770199

Cerebrovascular Complications and Vessel Wall Imaging in COVID-19 Encephalopathy-A Pilot Study.

Marjolaine Uginet1, Gautier Breville1, Jérémy Hofmeister2, Paolo Machi2, Patrice H Lalive1, Andrea Rosi2, Aikaterini Fitsiori2, Maria Isabel Vargas2, Frederic Assal1, Gilles Allali1,3, Karl-Olof Lovblad4.   

Abstract

BACKGROUND AND
PURPOSE: Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with several complications of the central nervous system (CNS), including acute encephalopathy.
METHODS: In this pilot study, we report a series of 39 patients (66.5 ± 9.2 years; 10.3% female) with acute encephalopathy, who underwent a standard brain magnetic resonance imaging (MRI) at 1.5 T during the acute symptomatic phase. In addition to diffusion-weighted imaging, MR angiography and susceptibility-weighted images, high-resolution vascular black blood sequences (in 34 cases) were used to investigate the vasculature of the brain.
RESULTS: In 29 out of 34 patients with COVID-19 encephalopathy (85%) with high-resolution vessel wall imaging, we found a circular enhancement and thickening of the basilar and vertebral arteries, without any correlation with ischemia or microbleeds (reported in 21% and 59%, respectively).
CONCLUSION: We report a high prevalence of vascular changes suggestive of endotheliitis as reported in other organs. This could suggest an inflammatory mechanism underlying this encephalopathy.
© 2021. The Author(s).

Entities:  

Keywords:  Contrast agent; Diffusion; Inflammation; MRI; SWI; Stroke

Mesh:

Year:  2021        PMID: 33770199      PMCID: PMC7995679          DOI: 10.1007/s00062-021-01008-2

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  3 in total

1.  Persistence of Clinically Significant Portal Hypertension After Eradication of Hepatitis C Virus in Patients With Advanced Cirrhosis.

Authors:  Cristina Díez; Juan Berenguer; Luis Ibañez-Samaniego; Elba Llop; Leire Pérez-Latorre; María V Catalina; Víctor Hontañón; María A Jiménez-Sousa; Teresa Aldámiz-Echevarría; Javier Martínez; José Luis Calleja; Agustín Albillos; José M Bellón; Salvador Resino; Juan González-García; Rafael Bañares
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

2.  Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses.

Authors:  Thibault Willaume; François Lersy; Jean-Christophe Brisset; Olivier Collange; Julie Helms; Francis Schneider; Agathe Chammas; Alexandre Willaume; Nicolas Meyer; Mathieu Anheim; François Cotton; Stéphane Kremer
Journal:  J Neurol       Date:  2020-11-21       Impact factor: 4.849

3.  Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19.

Authors:  Daniel Kirschenbaum; Lukas L Imbach; Elisabeth J Rushing; Katrin B M Frauenknecht; Dominic Gascho; Benjamin V Ineichen; Emanuela Keller; Sibylle Kohler; Mona Lichtblau; Regina R Reimann; Katharina Schreib; Silvia Ulrich; Peter Steiger; Adriano Aguzzi; Karl Frontzek
Journal:  Neuropathol Appl Neurobiol       Date:  2020-12-14       Impact factor: 6.250

  3 in total
  10 in total

1.  SCD14-ST and New Generation Inflammatory Biomarkers in the Prediction of COVID-19 Outcome.

Authors:  Emanuela Galliera; Luca Massaccesi; Lina Yu; Jianwen He; Marco Ranucci; Massimiliano M Corsi Romanelli
Journal:  Biomolecules       Date:  2022-06-13

2.  Vessel wall imaging in COVID-19 associated carotid atherothrombosis and stroke: a case report and literature review.

Authors:  Mohamad Syafeeq Faeez Md Noh; Abdul Hanif Khan Yusof Khan; Mohd Naqib Mohd Sabri; Mohd Fandi Al-Khafiz Kamis; Mohd Naim Mohd Yaakob; Ezamin Abdul Rahim; Ahmad Sobri Muda
Journal:  J Cent Nerv Syst Dis       Date:  2022-07-08

3.  Evolution of Neuroimaging Findings in Severe COVID-19 Patients with Initial Neurological Impairment: An Observational Study.

Authors:  François Lersy; Caroline Bund; Mathieu Anheim; Mary Mondino; Vincent Noblet; Shirley Lazzara; Clelie Phillipps; Olivier Collange; Walid Oulehri; Paul-Michel Mertes; Julie Helms; Hamid Merdji; Maleka Schenck; Francis Schneider; Julien Pottecher; Céline Giraudeau; Agathe Chammas; François-Daniel Ardellier; Seyyid Baloglu; Khalid Ambarki; Izzie Jacques Namer; Stéphane Kremer
Journal:  Viruses       Date:  2022-05-01       Impact factor: 5.818

4.  COVID-19 associated intracranial vasculopathy-MRI vessel wall imaging as adjunct to emergent CT angiography-a case report.

Authors:  David Raban; Krystle Barhaghi; Vincent Timpone; William Jones; Brian Sauer; Rebecca Pollard; Andrew Callen
Journal:  Emerg Radiol       Date:  2021-05-26

5.  The etiology of SARS-CoV-.2 associated intra-cranial hemorrhage is broad.

Authors:  Josef Finsterer; Fulvio Alexandre Scorza; Daniel Matovu
Journal:  Brain Hemorrhages       Date:  2022-01-05

6.  High-resolution intracranial vessel wall imaging in cerebral viral infections evaluations.

Authors:  Sameer Vyas; Neha Choudhary; Manish Modi; Naveen Sankhyan; Renu Suthar; Arushi Gahlot Saini; Arun Bansal; Navneet Sharma; Paramjeet Singh
Journal:  Neuroradiology       Date:  2021-10-16       Impact factor: 2.995

7.  Vessel wall magnetic resonance imaging in COVID-19-associated cryptogenic ischemic stroke.

Authors:  Federico Mazzacane; Antonio Zito; Serena Magno; Alessandra Persico; Valentina Mazzoleni; Carlo Asteggiano; Elisa Rognone; Anna Pichiecchio; Alessandro Padovani; Anna Cavallini; Andrea Morotti
Journal:  Eur J Neurol       Date:  2021-10-06       Impact factor: 6.288

8.  Therapeutic Approaches to the Neurologic Manifestations of COVID-19.

Authors:  Edith L Graham; Igor J Koralnik; Eric M Liotta
Journal:  Neurotherapeutics       Date:  2022-07-21       Impact factor: 6.088

9.  Neuroimaging in patients with COVID-19: a neuroradiology expert group consensus.

Authors:  Stéphane Kremer; Simonetta Gerevini; Ana Ramos; François Lersy; Tarek Yousry; Meike W Vernooij; Nicoletta Anzalone; Hans Rolf Jäger
Journal:  Eur Radiol       Date:  2022-01-19       Impact factor: 7.034

Review 10.  The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline.

Authors:  Jeffrey D Pyne; Adam M Brickman
Journal:  Neurodegener Dis       Date:  2021-07-28       Impact factor: 2.977

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.